LONDON (Alliance News) - NASDAQ-listed Myland Inc said Thursday that it has won its breach of contract case against UK pharmaceutical giant GlaxoSmithKline PLC. The jury of the United States District Court for New Jersey decided that Glaxo owes Mylan USD106.7 million in damages, over charge Read More
CANONSBURG (Alliance News) - Mylan Inc. said Thursday that, after a trial in the US District Court for the District of New Jersey, a jury returned a verdict in favour of Mylan in its breach of contract lawsuit against GlaxoSmithKline relating to Paroxetine Hydrochloride Extended-release or ER Tab Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday announced a new research collaboration with the European Bioinformatics Institute and the Wellcome Trust Sanger Institute, to harness 'big data' and genome sequencing to improve the success rate for discovering new medicines. The three w Read More
LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of <strong>Lloyds Banking</strong> Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.< Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said it had withdrawn its European marketing authorisation application for the combined use of Meikinist and Tafinlar for the treatment of unresectable or metastatic melanoma with a BRAF V600 mutation. This was as a result of the Commit Read More
LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br /><strong>----------</strong><br /><strong>COMPANIES</strong><br />----------<br />The UK government said it has raised GBP4.2 billion in its sale of a second tranche of <strong>Lloyds Banking</strong> Group Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said it had withdrawn its marketing authorisation application for the combined use of Meikinist and Tafinlar for the treatment of unresectable or metastatic melanoma with a BRAF V600 mutation in Europe. This was as a result of the Commi Read More
LONDON (Alliance News) - UK equities are attempting to rebalance today in the wake of the tax and regulatory changes unveiled in Wednesday's government budget.<br /><br />Life insurance companies have continued to take a battering during morning trading, following the announcement by Chancello Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br /><br />-------<br /><br /><strong>FTSE 100 - WINNERS</strong><br /><br /><strong>Next</strong>, up 1.9%. The homeware and clothing retailer reported higher profi Read More
LONDON (Alliance News) - The following is a summary of top news stories Thursday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Next</strong> PLC reported higher profits and revenues for the financial year ended January 2014 driven by its online business, raised Read More
LONDON (Alliance News) - Shares have opened lower Thursday, as markets around the world react to Fed Chair Janet Yellen's hint of an earlier-than-expected rise in US interest rates. The CEO of handbag firm <strong>Mulberry</strong> has stepped down after only two years in the job. <br /> Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said that a late stage trial of its MAGE-A3 cancer immunotherapeutic for patients with non-small-cell lung cancer did not meet two of its co-primary endpoints, as it failed to extend disease-free survival compared to a placebo. It did no Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:<br /><strong>----------</strong><br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE CUTS HSBC TO 'UNDERPERFORM' ('OUTPERFORM,') - PRICE TARGET 580 (780) PENCE <br />----------<br Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said Moncef Slaoui, chairman of research and development, acquired American Depositary Shares at USD54.23 each Friday.<br /><br />Details are as follows. <table class="ak" style="width: 419px; height: 130px;" cellspacing="0" cellpadding="0 Read More
LONDON (Alliance News) - It's all about retailers Thursday, with the listed supermarkets all down sharply due to even weaker-than-expected results and a warning about this year from <strong>Wm Morrison Supermarkets</strong>, while Argos and Homebase parent <strong>Home Retail</strong> rose sha Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said a pivotal phase III study of mepolizumab, an investigational IL-5 antagonist monoclonal antibody, has met its primary endpoint of reduction in the frequency of exacerbations, in patients with severe eosinophilic asthma. The study e Read More
LONDON (Alliance News) - The FTSE 100 overturned early strength to close lower Monday, as investors digested some weaker-than-expected Chinese trade data released over the weekend, amid a lack of fresh major macro-economic data releases. A report from the Chinese General Administration of C Read More
LONDON (Alliance News) - London's capital markets continued a resurgence Monday as two more companies announced that they intend to list, another started trading, and AIM-listed <strong>Fyffes PLC</strong> said it would be acquired by Chiquita Brands International Inc of the US in a deal that Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />Chiquita Brands International Inc and <strong>Fyffes</strong> PLC said they have reached a deal whereby Chiquita will acquire Fyffes to create th Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />DEUTSCHE BANK CUTS ROLLS-ROYCE PRICE TARGET TO 860 (1090) PENCE - 'SELL'<br />----------<br />MERRILL LYNCH Read More